Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07530653) titled 'Delayed Fluids in Hemorrhagic Shock Due to Severe Injuries' on April 9.

Study Type: Observational

Primary Sponsor: Hospital Departamental de Villavicencio

Condition: Trauma and Emergency Care Shock,Hemorrhagic Intravenous Fluid Therapy

Intervention: Drug: Crystalloid below 1000 mL.

Recruitment Status: Not recruiting

Date of First Enrollment: October 1, 2026

Target Sample Size: 716

Countries of Recruitment: Colombia

To know more, visit https://clinicaltrials.gov/study/NCT07530653

Disclaimer: Curated by HT Syndication....